We found that tumor volumes and weights were obviously smaller in the ESM1 inhibition group than in the vector group (Figure 9A-C), which indicated that ESM1 could promote the tumorigenicity of OC cells in vivo. The gene discussed is ESM1; the disease is neoplasm.